+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

4D Bioprinting Market by Type of Technology, Application Area, End-user and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

  • PDF Icon

    Report

  • 231 Pages
  • January 2023
  • Region: Global
  • Roots Analysis
  • ID: 5715075

The concept of 3D printing has been one of the biggest revolutions across the globe. Various industry stakeholders and academicians have undertaken several initiatives to further develop / improve this technology for a variety of applications. One such application area is 3D bioprinting that includes the printing of living cells and enables the development of highly complex tissues that mimic the structure and performance ability of desired organ, within the body. Although 3D bioprinting results in the printing of an exact replica of primary human organs, however, the printed 3D objects are inert and static in nature and are unable to change shape when subjected to environmental changes. 4D bioprinting makes this possible; 4D bioprinting refers to the incorporation of a fourth dimension that enables these structures to change their shape with time. The additional element in the bioprinting technology that enables the fourth dimension, includes application of smart materials, which have the tendency to morph in the presence of stimuli (such as, heat, water, light, electricity, magnetic energy, stress, strain, and pressure). In addition to the ability to morph, structures from 4D printing, have the ability to self-repair and can adapt to various environmental changes. This technology, though, is currently associated with several challenges; these include printing the existing stimuli-responsive materials and optimizing them with bio-inks. Assembling and folding deformations in structures from 4D printing is also quite demanding.

Owing to the ongoing advancements in the 4D biofabrication technology, several players are actively adopting and developing 4D bioprinters and smart biomaterials. It is worth highlighting that 4D bioprinting is garnering a lot of attention from academicians and industry players. In fact, the volume of affiliated scientific literature has increased at a rate of ~130% since last five years, demonstrating the growing popularity of 4D bioprinting. Further, looking at the wide range of applications associated with the 4D bioprinting, such as tissue engineering, regenerative medicine, and drug related applications, a number of start-ups have also emerged in this domain. Given the rising interest of stakeholders towards technological advancements and growing adoption of 4D bioprinting for above mentioned applications, we believe that the overall market for 4D bioprinting is anticipated to witness substantial growth in the coming years.

Scope of the Report

The 4D Bioprinting Market by Type of Technology (Extrusion-based Technology, Laser-based Technology, Inkjet-based Technology and Others), Application Area (Biomedical Applications and Others), End-user (Pharmaceutical and Biotechnology Companies, Academic Research and Development and Other End-users) and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America and Middle East and North Africa): Industry Trends and Global Forecasts, 2023-2035 report features an extensive study of the current market landscape and future potential of the 4D bioprinting market. The study features an in-depth analysis, highlighting the capabilities of 4D bioprinter and smart biomaterial developers.

Amongst other elements, the report includes:

  • An executive summary of the key insights captured during our research. It offers a high-level view on the likely evolution of the 4D bioprinting market in the short to mid-term, and long term.
  • A general overview of the 4D bioprinting and its working principle, which features details on the different stimuli responsive materials used in 4D bioprinting (including, physical and chemical stimulus). Further, the chapter includes details on the various technologies (such as, stereolithography, selective laser sintering, fused filament modeling, jet 3D printing, direct ink writing and selective laser melting) being used in 4D bioprinting. The chapter concludes with a discussion on the applications, limitations associated and factors which would lead to projected growth in the coming years.
  • A detailed assessment of the current market landscape of 4D bioprinters, featuring information on the status of development (commercial and under development), type of biomaterial (natural, polymer, synthetic, ceramic and others / undisclosed), type of technology (extrusion-based technology, polymer-based technology, laser-based technology, micro-valve technology, electro-writing, fused filament fabrication, vector technology and others / undisclosed), type of stimulus used (heat, light, moisture and others / undisclosed), product specifications (remote accessibility, and software and service), applications area(s) (tissue engineering and regenerative medicine, wound healing, electronics, drug discovery and development, orthopedics and others) and end-user(s) (academic and pharmaceutical and biotechnology companies). In addition to this, the chapter features information on 4D bioprinter developers and a detailed analysis based on several relevant parameters, such as year of establishment, company size (in terms of employee count) and location of headquarters (North America, Europe, Asia-Pacific and Rest of the World).
  • A detailed assessment of the current market landscape of smart biomaterials, featuring information on the status of development (commercial and under development), type of biomaterial (polymer, metallic, natural and others / undisclosed), form of biomaterial (sheet, liquid, gel, fibre, versatile and others / undisclosed), type of stimulus used (heat, electric field, magnetic field, moisture, enzymes / chemicals and others / undisclosed) and application area(s) (tissue engineering and regenerative medicine, wound healing, drug-based applications, orthopedics and others). In addition to this, the chapter features information on smart biomaterial developers and a detailed analysis based on several relevant parameters, such as year of establishment, company size (in terms of employee count) and location of headquarters (North America, Europe, Asia-Pacific and Rest of the World).
  • A benchmarking analysis of the various players engaged in developing 4D bioprinters and smart biomaterials. It highlights the capabilities of the players in terms of their expertise across the products developed or under development. The analysis allows companies to compare their existing capabilities within and beyond their peer groups and identify opportunities to gain a competitive edge in the industry. 
  • A detailed competitiveness analysis of 4D bioprinters, taking into consideration several relevant parameters, such as product strength (including, commercial status, type of biomaterials, type of technologies used, type of stimulus used and number of specifications) and product diversity (including, application area(s) and end-user(s)).
  • Tabulated profiles of the key players involved in developing 4D bioprinters and smart biomaterials. Each profile features a brief overview of the company, its financial information (if available), details on its product portfolio, recent developments and an informed future outlook.
  • An in-depth analysis of various publications for 4D bioprinting, based on several relevant parameters, such as year of publication, type of article, emerging key focus areas, popular publishers (in terms of number of publications), popular journals (in terms of number of number of publications), journal impact factor, popular journals (in terms of journal impact factor) and popular funding bodies (in terms of number of publications). It also highlights the timeline analysis (by article type and journal impact factor), along with the benchmarking of the publications to develop more insightful opinions on the recent trends related to research and development in this area. 
  • A qualitative analysis of the five competitive forces, including threats of new entrants, bargaining power of buyers, bargaining power of suppliers, threats of substitute products and rivalry among existing companies under an insightful Porter’s Five Forces framework.

One of the key objectives of the report was to evaluate the current opportunity and future potential associated with the 4D bioprinting market, over the coming 12 years. We have provided informed estimates of the likely evolution of the market in the short to mid-term, and long term, for the period 2023-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as type of technology (extrusion-based technology, laser-based technology, inkjet-based technology and others), application area (biomedical applications and others), end-user (pharmaceutical and biotechnology companies, academic research and development and other end-users), key geographical regions (North America, Europe, Asia-Pacific, Latin America and Middle East and North Africa). To account for future uncertainties in the market and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution.

The opinions and insights presented in the report were also influenced by discussions held with senior stakeholders in the industry.

The report features detailed transcripts of interviews held with the following individuals:

  • Suhridh Sundaram (Chief Operating Officer, Avay Biosciences)
  • Preethem Srinath (Doctoral Candidate, CURAM)
  • Sam Onukuri (Independent Consultant, the US)

Frequently Asked Questions

  • What is meant by 4D Bioprinting?
  • How does 4D bioprinting work?
  • What are the benefits of 4D Bioprinting?
  • Who are the leading developers of 4D bioprinters and smart biomaterials?
  • Which is the hub of 4D bioprinter and smart biomaterial developers?
  • What is the relative competitiveness of different 4D bioprinter and smart biomaterial developers?
  • What is the relative competitiveness of different 4D bioprinters?
  • What are the strengths and threats for the developers engaged in the 4D bioprinting industry?
  • What is the focus of various publications related to 4D bioprinting? 
  • What is the current / future market of 4D bioprinting?

Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Market Segmentation
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of 4D Bioprinting
3.3. Working Principle of 4D Bioprinting
3.3.1. Stimuli Responsive Materials in 4D Bioprinting
3.3.1.1. Materials Responding to Physical Stimulus
3.3.1.2. Materials Responding to Chemical Stimulus
3.3.2. Technologies Used in 4D Bioprinting
3.4. Applications of 4D Bioprinting
3.5. Limitations Associated with 4D Bioprinting
3.6. Future Perspectives

4. 4D BIOPRINTERS: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. 4D Bioprinters: Overall Market Landscape
4.2.1. Analysis by Status of Development
4.2.2. Analysis by Type of Biomaterial
4.2.3. Analysis by Status of Development and Type of Biomaterial
4.2.4. Analysis by Type of Technology
4.2.5. Analysis by Status of Development and Type of Technology
4.2.6. Analysis by Type of Stimulus Used
4.2.7. Analysis by Status of Development and Type of Stimulus Used
4.2.8. Analysis by Product Specifications
4.2.9. Analysis by Application Area(s)
4.2.10. Analysis by End-User(s)
4.3. 4D Bioprinter Developers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters (Region-wise)
4.3.4. Analysis by Company Size and Location of Headquarters (Region-wise)
4.3.5. Analysis by Location of Headquarters (Country-wise)

5. SMART BIOMATERIALS: MARKET LANDSCAPE
5.1. Chapter Overview
5.2. Smart Biomaterials: Overall Market Landscape
5.2.1. Analysis by Status of Development
5.2.2. Analysis by Type of Biomaterial
5.2.3. Analysis by Status of Development and Type of Biomaterial
5.2.4. Analysis by Form of Biomaterial
5.2.5. Analysis by Type of Stimulus Used
5.2.6. Analysis by Status of Development and Type of Stimulus Used
5.2.7. Analysis by Application Area(s)
5.3. Smart Biomaterials Developers
5.3.1. Analysis by Year of Establishment
5.3.2. Analysis by Company Size
5.3.3. Analysis by Location of Headquarters (Region-wise)
5.3.4. Analysis by Company Size and Location of Headquarters (Region-wise)
5.3.5. Analysis by Location of Headquarters (Country-wise)

6. BENCHMARKING ANALYSIS
6.1. Chapter Overview
6.2. Benchmarking Analysis: 4D Bioprinter Developers
6.2.1. Assumptions and Key Parameters
6.2.2. Methodology
6.2.3. Benchmarking Analysis: Peer Groups
6.2.3.1. Benchmarking Analysis: North America (Peer Group I)
6.2.3.2. Benchmarking Analysis: North America (Peer Group II)
6.2.3.3. Benchmarking Analysis: Europe, Asia-Pacific and Rest of the World (Peer Group III)
6.2.3.4. Benchmarking Analysis: Europe, Asia-Pacific and Rest of the World (Peer Group IV)
6.2.3.5. Benchmarking Analysis: Europe, Asia-Pacific and Rest of the World (Peer Group V)
6.3. Benchmarking Analysis: Smart Biomaterials Developers
6.3.1. Assumptions and Key Parameters
6.3.2. Methodology
6.3.3. Benchmarking Analysis: Peer Groups
6.3.3.1. Benchmarking Analysis: North America (Peer Group I)
6.3.3.2. Benchmarking Analysis: North America (Peer Group II)
6.3.3.3. Benchmarking Analysis: Europe, Asia-Pacific and Rest of the World (Peer Group III)
6.3.3.4. Benchmarking Analysis: Europe, Asia-Pacific and Rest of the World (Peer Group IV)
6.3.3.5. Benchmarking Analysis: Europe, Asia-Pacific and Rest of the World (Peer Group V)
6.4. Concluding Remarks

7. PRODUCT COMPETITIVENESS ANALYSIS
7.1. Chapter Overview
7.2. Assumptions and Key Parameters
7.3. Methodology
7.4. Product Competitiveness Analysis: Analysis by Location of Headquarters of 4D Bioprinter Developers
7.4.1. Product Competitiveness Analysis: 4D Bioprinters Developed by North America based Players
7.4.2. Product Competitiveness Analysis: 4D Bioprinters Developed by Europe based Players
7.4.3. Product Competitiveness Analysis: 4D Bioprinters Developed by Asia-Pacific and Rest of the World-based Players

8. COMPANY PROFILES
8.1. Chapter Overview
8.2. List of 4D Bioprinter Developers
8.2.1. Poietis
8.2.1.1. Company Overview
8.2.1.2. Product Portfolio
8.2.1.3. Recent Developments and Future Outlook
8.2.2. REGENHU
8.2.2.1. Company Overview
8.2.2.2. Product Portfolio
8.2.2.3. Recent Developments and Future Outlook
8.2.3. ROKIT Healthcare
8.2.3.1. Company Overview
8.2.3.2. Product Portfolio
8.2.3.3. Recent Developments and Future Outlook
8.2.4. SMART3D
8.2.4.1. Company Overview
8.2.4.2. Product Portfolio
8.2.4.3. Recent Developments and Future Outlook
8.2.5. Stratasys
8.2.5.1.1. Company Overview
8.2.5.1.2. Financial Information
8.2.5.1.3. Product Portfolio
8.2.5.1.4. Recent Developments and Future Outlook
8.2.6. VIVAX BIO
8.2.6.1. Company Overview
8.2.6.2. Product Portfolio
8.2.6.3. Recent Developments and Future Outlook
8.3. List of Smart Biomaterials Developers
8.3.1. DirectSync Surgical
8.3.1.1. Company Overview
8.3.1.2. Product Portfolio
8.3.1.3. Recent Developments and Future Outlook
8.3.2. Enovis
8.3.2.1. Company Overview
8.3.2.2. Financial Information
8.3.2.3. Product Portfolio
8.3.2.4. Recent Developments and Future Outlook
8.3.3. Ferentis
8.3.3.1. Company Overview
8.3.3.2. Product Portfolio
8.3.3.3. Recent Developments and Future Outlook
8.3.4. Sculpteo
8.3.4.1. Company Overview
8.3.4.2. Product Portfolio
8.3.4.3. Recent Developments and Future Outlook

9. PUBLICATION BENCHMARKING ANALYSIS
9.1. Chapter Overview
9.2. Scope and Methodology
9.2.1. Analysis by Year of Publication
9.2.2. Analysis by Type of Article
9.2.3. Word Cloud Analysis: Emerging Focus Areas
9.2.4. Popular Publishers: Analysis by Number of Publications
9.2.5. Popular Journals: Analysis by Number of Publications
9.2.6. Analysis by Journal Impact Factor
9.2.7. Popular Journals: Analysis by Journal Impact Factor
9.2.8. Popular Funding Bodies: Analysis by Number of Publications
9.2.9. Publications: Timeline Analysis
9.2.9.1. Timeline Analysis of Article Type
9.2.9.2. Timeline Analysis of Journal Impact Factor Range
9.2.10. Publication Benchmarking

10. PORTER’S FIVE FORCES ANALYSIS
10.1. Chapter Overview
10.2. Assumptions and Key Parameters
10.3. Methodology
10.3.1. Threats of New Entrants
10.3.2. Bargaining Power of Buyers
10.3.3. Bargaining Power of Suppliers
10.3.4. Threats of Substitute Products
10.3.5. Rivalry Among Existing Companies
10.4. Concluding Remarks

11. MARKET FORECAST AND OPPORTUNITY ANALYSIS
11.1. Chapter Overview
11.2. Forecast Methodology and Key Assumptions
11.3. Overall 4D Bioprinting Market, 2023-2035
11.3.1. 4D Bioprinting Market, 2028 and 2035: Distribution by Type of Technology
11.3.1.1. 4D Bioprinting Market for Extrusion-based Technology, 2023-2035
11.3.1.2. 4D Bioprinting Market for Laser-based Technology, 2023-2035
11.3.1.3. 4D Bioprinting Market for Inkjet-based Technology, 2023-2035
11.3.1.4. 4D Bioprinting Market for Other Technologies, 2023-2035
11.3.2. 4D Bioprinting Market, 2028 and 2035: Distribution by Application Area
11.3.2.1. 4D Bioprinting Market for Biomedical Applications, 2023-2035
11.3.2.2. 4D Bioprinting Market for Other Applications, 2023-2035
11.3.3. 4D Bioprinting Market, 2028 and 2035: Distribution by End-User
11.3.3.1. 4D Bioprinting Market for Pharmaceutical and Biotechnology Companies, 2023-2035
11.3.3.2. 4D Bioprinting Market for Academic Research and Development, 2023-2035
11.3.3.3. 4D Bioprinting Market for Other End-Users, 2023-2035
11.3.4. 4D Bioprinting Market, 2028 and 2035: Distribution by Key Geographical Regions
11.3.4.1. 4D Bioprinting Market in North America, 2023-2035
11.3.4.2. 4D Bioprinting Market in Europe, 2023-2035
11.3.4.3. 4D Bioprinting Market in Asia-Pacific, 2023-2035
11.3.4.4. 4D Bioprinting Market in Latin America, 2023-2035
11.3.4.5. 4D Bioprinting Market in Middle East and North Africa, 2023-2035

12. CONCLUDING REMARKS

13. EXECUTIVE INSIGHTS
13.1. Chapter Overview
13.2. Avay Biosciences
13.2.1. Company Overview
13.2.2. Interview Transcript: Suhridh Sundaram (Chief Operating Officer)
13.3. CURAM
13.3.1. Company Overview
13.3.2. Interview Transcript: Preethem Srinath (Doctoral Candidate)
13.3. Independent Consultant
13.3.1. Interview Transcript: Sam Onukuri

14. APPENDIX I: TABULATED DATA

15. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures
Figure 2.1 Executive Summary: Current Market Landscape of 4D Bioprinters
Figure 2.2 Executive Summary: Current Market Landscape of Smart Biomaterials
Figure 2.3 Executive Summary: Publication Benchmarking Analysis
Figure 2.4 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Steps Involved in Bioprinting
Figure 3.2 Steps Involved in 4D Bioprinting
Figure 3.3 Laws of 4D Printing Structures
Figure 3.4 Limitations Associated with 4D Bioprinting
Figure 4.1 4D Bioprinters: Distribution by Status of Development
Figure 4.2 4D Bioprinters: Distribution by Type of Biomaterial
Figure 4.3 4D Bioprinters: Distribution by Status of Development and Type of Biomaterial
Figure 4.4 4D Bioprinters: Distribution by Type of Technology
Figure 4.5 4D Bioprinters: Distribution by Status of Development and Type of Technology
Figure 4.6 4D Bioprinters: Distribution by Type of Stimulus Used
Figure 4.7 4D Bioprinters: Distribution by Status of Development and Type of Stimulus Used
Figure 4.8 4D Bioprinters: Distribution by Product Specifications
Figure 4.9 4D Bioprinters: Distribution by Application Area(s)
Figure 4.10 4D Bioprinters: Distribution by End-User(s)
Figure 4.11 4D Bioprinter Developers: Distribution by Year of Establishment
Figure 4.12 4D Bioprinter Developers: Distribution by Company Size
Figure 4.13 4D Bioprinter Developers: Distribution by Location of Headquarters (Region-wise)
Figure 4.14 4D Bioprinter Developers: Distribution by Company Size and Location of Headquarters (Region-wise)
Figure 4.15 4D Bioprinter Developers: Distribution by Location of Headquarters (Country-wise)
Figure 5.1 Smart Biomaterials: Distribution by Status of Development
Figure 5.2 Smart Biomaterials: Distribution by Type of Biomaterial
Figure 5.3 Smart Biomaterials: Distribution by Status of Development and Type of Biomaterial
Figure 5.4 Smart Biomaterials: Distribution by Form of Biomaterial
Figure 5.5 Smart Biomaterials: Distribution by Type of Stimulus Used
Figure 5.6 Smart Biomaterials: Distribution by Status of Development and Type of Stimulus Used
Figure 5.7 Smart Biomaterials: Distribution by Application Area(s)
Figure 5.8 Smart Biomaterials Developers: Distribution by Year of Establishment
Figure 5.9 Smart Biomaterials Developers: Distribution by Company Size
Figure 5.10 Smart Biomaterials Developers: Distribution by Location of Headquarters (Region-wise)
Figure 5.11 Smart Biomaterials Developers: Distribution by Company Size and Location of Headquarters (Region-wise)
Figure 5.12 Smart Biomaterials Developers: Distribution by Location of Headquarters (Country-wise)
Figure 6.1 Benchmarking Analysis (4D Bioprinter Developers): Distribution by Location of Headquarters and Company Size
Figure 6.2 Competitive Benchmarking: Distribution of Very Small and Small Players based in North America (Peer Group I)
Figure 6.3 Competitive Benchmarking: Distribution of Mid-Sized, Large and Very Large Players based in North America (Peer Group II)
Figure 6.4 Competitive Benchmarking: Distribution of Very Small and Small Players based in Europe, Asia-Pacific and Rest of the World (Peer Group III)
Figure 6.5 Competitive Benchmarking: Distribution of Mid-sized Players based in Europe, Asia-Pacific and Rest of the World (Peer Group IV)
Figure 6.6 Competitive Benchmarking: Distribution of Large and Very Large Players based in Europe, Asia-Pacific and Rest of the World (Peer Group V)
Figure 6.7 Benchmarking Analysis (Smart Biomaterial Developers): Distribution by Location of Headquarters and Company Size
Figure 6.8 Competitive Benchmarking: Distribution of Very Small and Small Players based in North America (Peer Group I)
Figure 6.9 Competitive Benchmarking: Distribution of Large and Very Large Players based in North America (Peer Group II)
Figure 6.10 Competitive Benchmarking: Distribution of Very Small and Small Players based in Europe, Asia-Pacific and Rest of the World (Peer Group III)
Figure 6.11 Competitive Benchmarking: Distribution of Mid-sized Players based in Europe, Asia-Pacific and Rest of the World (Peer Group IV)
Figure 6.12 Competitive Benchmarking: Distribution of Large and Very Large Players based in Europe, Asia-Pacific and Rest of the World (Peer Group V)
Figure 7.1 Product Competitiveness Analysis: Distribution of 4D Bioprinters Developed by North America based Players
Figure 7.2 Product Competitiveness Analysis: Distribution of 4D Bioprinters Developed by Europe based Players
Figure 7.3 Product Competitiveness Analysis: Distribution of 4D Bioprinters Developed by Asia-Pacific and Rest of the World based Players
Figure 8.1 Stratasys: Annual Revenues, 2017-H1 2022 (USD Million)
Figure 8.2 Enovis: Annual Revenues, 2017-H1 2022 (USD Billion)
Figure 9.1 Publication Benchmarking Analysis: Cumulative Year-wise Trend, 2016-2022
Figure 9.2 Publication Benchmarking Analysis: Distribution by Type of Article
Figure 9.3 Word Cloud Analysis: Emerging Focus Areas
Figure 9.4 Popular Publishers: Distribution by Number of Publications
Figure 9.5 Popular Journals: Distribution by Number of Publications
Figure 9.6 Publications Benchmarking Analysis: Distribution by Journal Impact Factor
Figure 9.7 Popular Journals: Distribution by Journal Impact Factor
Figure 9.8 Popular Funding Bodies: Distribution by Number of Publications
Figure 9.9 Publication Benchmarking
Figure 10.1 Porter’s Five Forces: Key Parameters
Figure 10.2 Porter’s Five Forces: Harvey Ball Analysis
Figure 11.1 Global 4D Bioprinting Market, 2023-2035 (USD Million)
Figure 11.2 4D Bioprinting Market: Distribution by Type of Technology, 2028 and 2035 (USD Million)
Figure 11.3 4D Bioprinting Market for Extrusion-based Technology, 2023-2035 (USD Million)
Figure 11.4 4D Bioprinting Market for Laser-based Technology, 2023-2035 (USD Million)
Figure 11.5 4D Bioprinting Market for Inkjet-based Technology, 2023-2035 (USD Million)
Figure 11.6 4D Bioprinting Market for Other Technologies, 2023-2035 (USD Million)
Figure 11.7 4D Bioprinting Market: Distribution by Application Area, 2028 and 2035 (USD Million)
Figure 11.8 4D Bioprinting Market for Biomedical Applications, 2023-2035 (USD Million)
Figure 11.9 4D Bioprinting Market for Other Applications, 2023-2035 (USD Million)
Figure 11.10 4D Bioprinting Market: Distribution by End-user, 2028 and 2035 (USD Million)
Figure 11.11 4D Bioprinting Market for Pharmaceutical and Biotechnology Companies, 2023-2035 (USD Million)
Figure 11.12 4D Bioprinting Market for Academic Research and Development, 2023-2035 (USD Million)
Figure 11.13 4D Bioprinting Market for Other End-users, 2023-2035 (USD Million)
Figure 11.14 4D Bioprinting Market: Distribution by Key Geographical Regions, 2028 and 2035 (USD Million)
Figure 11.15 4D Bioprinting Market in North America, 2023-2035 (USD Million)
Figure 11.16 4D Bioprinting Market in Europe, 2023-2035 (USD Million)
Figure 11.17 4D Bioprinting Market in Asia-Pacific, 2023-2035 (USD Million)
Figure 11.18 4D Bioprinting Market in Latin America, 2023-2035 (USD Million)
Figure 11.19 4D Bioprinting Market in Middle East and North Africa, 2023-2035 (USD Million)
Figure 12.1 Concluding Remarks: Current Market Landscape of 4D Bioprinters
Figure 12.2 Concluding Remarks: Current Market Landscape of Smart Biomaterials
Figure 12.3 Concluding Remarks: Publication Benchmarking Analysis
Figure 12.4 Concluding Remarks: Market Forecast and Opportunity Analysis

List Of Tables
Table 4.1 4D Bioprinters: Information on Status of Development and Type of Biomaterial
Table 4.2 4D Bioprinters: Information on Type of Technology and Type of Stimulus Used
Table 4.3 4D Bioprinters: Information on Product Specifications, Application Area(s) and End-user(s)
Table 4.4 4D Bioprinters Developers: Information on Year of Establishment, Number of Employees, Company Size, Location of Headquarters
Table 5.1 Smart Biomaterials: Information on Status of Development, Type of Biomaterial and Form of Biomaterial,
Table 5.2 Smart Biomaterials: Information on Type of Stimulus Used and Application Area(s),
Table 5.3 Smart Biomaterial Developers: Information on Year of Establishment, Number of Employees, Company Size, and Location of Headquarters
Table 6.1 Benchmarking Analysis (4D Bioprinter Developers): Information on Peer Groups
Table 6.2 Benchmarking Analysis (Smart Biomaterial Developers): Information on Peer Groups
Table 8.1 4D Bioprinter Developers: List of Companies Profiled
Table 8.2 Poietis: Company Overview
Table 8.3 Poietis: Product Portfolio
Table 8.4 Poietis: Recent Developments and Future Outlook
Table 8.5 REGENHU: Company Overview
Table 8.6 REGENHU: Product Portfolio
Table 8.7 REGENHU: Recent Developments and Future Outlook
Table 8.8 ROKIT Healthcare: Company Overview
Table 8.9 ROKIT Healthcare: Product Portfolio
Table 8.10 ROKIT Healthcare: Recent Developments and Future Outlook
Table 8.11 SMART3D: Company Overview
Table 8.12 SMART3D: Product Portfolio
Table 8.13 SMART3D: Recent Developments and Future Outlook
Table 8.14 Stratasys: Company Overview
Table 8.15 Stratasys: Product Portfolio
Table 8.16 Stratasys: Recent Developments and Future Outlook
Table 8.17 VIVAX BIO: Company Overview
Table 8.18 VIVAX BIO: Product Portfolio
Table 8.19 VIVAX BIO: Recent Developments and Future Outlook
Table 8.20 Smart Biomaterial Developers: List of Companies Profiled
Table 8.21 DirectSync Surgical: Company Overview
Table 8.22 DirectSync Surgical: Product Portfolio
Table 8.23 DirectSync Surgical: Recent Developments and Future Outlook
Table 8.24 Enovis: Company Overview
Table 8.25 Enovis: Product Portfolio
Table 8.26 Enovis: Recent Developments and Future Outlook
Table 8.27 Ferentis: Company Overview
Table 8.28 Ferentis: Product Portfolio
Table 8.29 Ferentis: Recent Developments and Future Outlook
Table 8.30 Sculpteo: Company Overview
Table 8.31 Sculpteo: Product Portfolio
Table 8.32 Sculpteo: Recent Developments and Future Outlook
Table 9.1 Timeline Analysis: Distribution by Type of Article and Average Time to Publish
Table 9.2 Timeline Analysis: Distribution by Type of Article and Maximum Time to Publish
Table 9.3 Timeline Analysis: Distribution by Type of Article and Minimum Time to Publish
Table 9.4 Timeline Analysis: Distribution by Journal Impact Factor and Average Time to Publish
Table 9.5 Timeline Analysis: Distribution by Journal Impact Factor and Maximum Time to Publish
Table 9.6 Timeline Analysis: Distribution by Journal Impact Factor and Minimum Time to Publish
Table 9.7 Publication Benchmarking: List of Top 35 Publications
Table 13.1 Avay Biosciences: Company Overview
Table 13.2 CURAM: Company Overview
Table 14.1 4D Bioprinters: Distribution by Status of Development
Table 14.2 4D Bioprinters: Distribution by Type of Biomaterial
Table 14.3 4D Bioprinters: Distribution by Status of Development and Type of Biomaterial
Table 14.4 4D Bioprinters: Distribution by Type of Technology
Table 14.5 4D Bioprinters: Distribution by Status of Development and Type of Technology
Table 14.6 4D Bioprinters: Distribution by Type of Stimulus Used
Table 14.7 4D Bioprinters: Distribution by Status of Development and Type of Stimulus Used
Table 14.8 4D Bioprinters: Distribution by Product Specifications
Table 14.9 4D Bioprinters: Distribution by Application Area(s)
Table 14.10 4D Bioprinters: Distribution by End-user(s)
Table 14.11 4D Bioprinter Developers: Distribution by Year of Establishment
Table 14.12 4D Bioprinter Developers: Distribution by Company Size
Table 14.13 4D Bioprinter Developers: Distribution by Location of Headquarters (Region-wise)
Table 14.14 4D Bioprinter Developers: Distribution by Company Size and Location of Headquarters (Region-wise)
Table 14.15 4D Bioprinter Developers: Distribution by Location of Headquarters (Country-wise)
Table 14.16 Smart Biomaterials: Distribution by Status of Development
Table 14.17 Smart Biomaterials: Distribution by Type of Biomaterial
Table 14.18 Smart Biomaterials: Distribution by Status of Development and Type of Biomaterial
Table 14.19 Smart Biomaterials: Distribution by Form of Biomaterial
Table 14.20 Smart Biomaterials: Distribution by Type of Stimulus Used
Table 14.21 Smart Biomaterials: Distribution by Status of development and Type of Stimulus Used
Table 14.22 Smart Biomaterials: Distribution by Application Area(s)
Table 14.23 Smart Biomaterials Developers: Distribution by Year of Establishment
Table 14.24 Smart Biomaterials Developers: Distribution by Company Size
Table 14.25 Smart Biomaterials Developers: Distribution by Location of Headquarters (Region-wise)
Table 14.26 Smart Biomaterials Developers: Distribution by Company Size and Location of Headquarters (Region-wise)
Table 14.27 Smart Biomaterials Developers: Distribution by Location of Headquarters (Country-wise)
Table 14.28 Benchmarking Analysis (4D Bioprinter Developers): Distribution by Location of Headquarters and Company Size
Table 14.29 Benchmarking Analysis (Smart Biomaterial Developers): Distribution by Location of Headquarters and Company Size
Table 14.30 Stratasys: Annual Revenues, 2017-H1 2022 (USD Million)
Table 14.31 Enovis: Annual Revenues, 2017-H1 2022 (USD Billion)
Table 14.32 Publication Benchmarking Analysis: Cumulative Year-wise Trend, 2016-2022
Table 14.33 Publication Benchmarking Analysis: Distribution by Type of Article
Table 14.34 Popular Publishers: Distribution by Number of Publications
Table 14.35 Popular Journals: Distribution by Number of Publications
Table 14.36 Publications Benchmarking Analysis: Distribution by Journal Impact Factor
Table 14.37 Popular Journals: Distribution by Journal Impact Factor
Table 14.38 Popular Funding Bodies: Distribution by Number of Publications
Table 14.39 Global 4D Bioprinting Market, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.40 4D Bioprinting Market: Distribution by Type of Technology, 2028 and 2035 (USD Million)
Table 14.41 4D Bioprinting Market for Extrusion-based Technology, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.42 4D Bioprinting Market for Laser-based Technology, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.43 4D Bioprinting Market for Inkjet-based Technology, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.44 4D Bioprinting Market for Other Technologies, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.45 4D Bioprinting Market: Distribution by Application Area, 2028 and 2035 (USD Million)
Table 14.46 4D Bioprinting Market for Biomedical Applications, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.47 4D Bioprinting Market for Other Applications, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.48 4D Bioprinting Market: Distribution by End-user, 2028 and 2035 (USD Million)
Table 14.49 4D Bioprinting Market for Pharmaceutical and Biotechnology Companies, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.50 4D Bioprinting Market for Academic Research and Development, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.51 4D Bioprinting Market for Other End-users, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.52 4D Bioprinting Market: Distribution by Key Geographical Regions, 2028 and 2035 (USD Million)
Table 14.53 4D Bioprinting Market in North America, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.54 4D Bioprinting Market in Europe, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.55 4D Bioprinting Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.56 4D Bioprinting Market in Latin America, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.57 4D Bioprinting Market in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)

Companies Mentioned

  • 3D Systems
  • 3d.FAB 
  • 3DBio Therapeutics
  • 4D Biomaterials
  • Avay Biosciences
  • BIH Center for Regenerative Therapies (BCRT)
  • BioG3D
  • Brighter 
  • CELLINK
  • CURAM
  • Production and Validation Center for Advanced Therapies (Creatio) 
  • DJO® (now part of Envis)
  • Duke University
  • ETH Zurich
  • Evoke Medical
  • Ferentis
  • First Graphene
  • GKSS Research Center Geesthacht
  • Grolltex
  • Guangzhou Medical University
  • Harvard Medical School
  • Harvard University
  • Institute of Polymer Research (Part of University of Waterloo)
  • Instituto de Nanociencia y Materiales de Aragón
  • Interdisciplinary Research Center of Autoimmune Diseases (Part of University of Eastern Piedmont)
  • Johnson and Johnson
  • Leibniz Institute of Polymer Research Dresden
  • Maastrich University
  • Massachusetts Institute of Technology
  • mimiX Biotherapeutics
  • mNEMOSCIENCE
  • Nano3D Biosciences
  • NanoBio Lab
  • National Interuniversity Consortium of Materials Science and Technology
  • National Natural Science Foundation of China
  • National Science Foundation
  • Nuclera
  • Ourobionics
  • PhotoPolymer
  • Poietis
  • Politecbico di Milano
  • Precise Bio
  • Readily3D
  • REGENHU
  • Rheolution
  • Ritsumeikan University
  • ROKIT Healthcare
  • Rutgers University
  • RWTH Aachen University
  • Sculpteo
  • Smart3D
  • Stratasys
  • The George Washington University
  • Tissue Regeneration Systems
  • TissueLabs
  • University of Bayreuth
  • University of Birmingham
  • University of California
  • University of Chicago
  • University of Eastern Piedmont
  • University of Georgia
  • University of Illinois
  • University of Illinois Chicago
  • University of Illinois Urbana-Champaign
  • University of Maryland
  • University of Tsukuba
  • University of Twente
  • University of Washington
  • University of Wollongong
  • Virginia Tech
  • VIVAX BIO
  • Wyss Institute for Biologically Inspired Engineering

Methodology

 

 

Loading
LOADING...